Accuray Incorporated (ARAY) support and resistance · rev $401.9M
Accuray Incorporated (ARAY) is a medical devices company listed on US.
This page maps Accuray Incorporated (ARAY) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported ARAY revenue for 2026-06-30 was $401.9M. Net income was -$49.2M. Revenue was down 12.3% from 2025-06-30 to 2026-06-30. ARAY currently screens at market cap $140.1M.
ARAY currently screens at market cap $140.1M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new ARAY 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the ARAY quote page for the session range and the stock page for the full model.
Not investment advice.